Electrogenic sodium bicarbonate cotransporter 4 (SLC4A5)

Electrogenic sodium bicarbonate cotransporter 4 (SLC4A5/NBCe2) is an integral membrane transporter protein encoded by the SLC4A5 gene. It mediates the co-transport of sodium (Na+) and bicarbonate (HCO3−) ions across cell membranes with a varying stoichiometry (typically 1Na+:2HCO3− to 1Na+:3HCO3−), generating an electrical current (electrogenic transport). It plays a critical role in maintaining intracellular pH, acid-base homeostasis, and sodium reabsorption, especially in the renal proximal tubule and collecting duct. SLC4A5 is widely expressed in tissues including the kidney, liver, brain, heart, and others. Genetic variants of SLC4A5 are associated with increased risk of salt-sensitive hypertension, making it an important disease susceptibility gene in cardiovascular health. The protein is functionally regulated by hormonal signaling (dopamine, angiotensin II) and transcription factors (HNF4A). Disruption or altered regulation of SLC4A5 impacts kidney function, blood pressure, and acid-base balance. Currently, there are no approved drugs directly targeting SLC4A5, but it is a potential therapeutic target for hypertension and related renal disorders.

Other names

SLC4A5NBC4NBCe2Solute carrier family 4 member 5Electrogenic sodium bicarbonate cotransporter 4Sodium bicarbonate cotransporter NBCe2

Inhibition of sodium-bicarbonate cotransport through direct block of transporter. Modulation via upstream pathways (dopamine, angiotensin II) altering expression or activity in renal cells. Experimental silencing by shRNA or gene editing. Antagonism of transcriptional regulators (e.g., HNF4A antagonists)—interfere with increased NBCe2 activity in salt-sensitive hypertension.